Arcadia Biosciences Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Arcadia Biosciences Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- RKDA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001469443
Board of directors
-
Albert D. Bolles · DirectorSince 2023
-
Amy Yoder · DirectorSince 2023
-
Deborah D. Carosella · DirectorSince 2023
-
Gregory D. Waller · DirectorSince 2023
-
Kevin Comcowich · DirectorSince 2023
-
Lilian Shackelford Murray · DirectorSince 2023
Director election results
Annual meeting of September 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
78.2%
Board connections
2 of this board's directors also sit on 2 other boards.
- via Amy Yoder
- via Gregory D. Waller
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 3, 2025 | Kawakami Mark Officer (Chief Financial Officer) | Open-market purchase | +700 | $2.49 | $1,743 |
| Feb 3, 2025 | Schaefer Thomas J. Officer (Chief Executive Officer) | Open-market purchase | +700 | $2.49 | $1,743 |
| Aug 1, 2024 | Kawakami Mark Officer (Chief Financial Officer) | Open-market purchase | +700 | $2.06 | $1,442 |
| Aug 1, 2024 | Schaefer Thomas J. Officer (Chief Executive Officer) | Open-market purchase | +700 | $2.06 | $1,442 |
| Feb 1, 2024 | Schaefer Thomas J. Officer (Chief Financial Officer) | Open-market purchase | +700 | $2.06 | $1,442 |
| Aug 4, 2023 | Schaefer Thomas J. Officer (Chief Financial Officer) | Open-market purchase | +649 | $3.67 | $2,382 |
| May 30, 2023 | Jacot Stanley Jr Officer (Chief Executive Officer) | Open-market purchase | +5,000 | $4.31 | $21,550 |
| Feb 1, 2023 | Schaefer Thomas J. Officer (Chief Financial Officer) | Open-market purchase | +700 | $0.23 | $161 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.